Bay Harbor Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bay Harbor Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.46K	Buy	13 +6	+86%	+$1.05K	﹤0.01%	512
2025 Q4	$1.19K	Buy	7 +2	+40%	+$307	﹤0.01%	594
2025 Q3	$659	Buy	5 +1	+25%	+$120	﹤0.01%	629
2025 Q2	$424	Buy	4 +2	+100%	+$217	﹤0.01%	697
2025 Q1	$248	Buy	+2	New	+$261	﹤0.01%	607

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Bay Harbor Wealth Management's JAZZ Position: Q1 2026 in Review

Bay Harbor Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 86% in Q1 2026, buying an estimated $1.05K and bringing the position to 13 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #512.

Bay Harbor Wealth Management first reported a position in JAZZ in Q1 2025 and has held it in 5 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Bay Harbor Wealth Management held 13 shares of Jazz Pharmaceuticals worth $2.46K as of Q1 2026.
Bay Harbor Wealth Management bought 6 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.05K.
Jazz Pharmaceuticals made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q1 2026, its #512 holding.
Bay Harbor Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.